ZOLMITRIPTAN SANOFI 2.5 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

zolmitriptan sanofi 2.5 milligram film coated tablet

sanofi-aventis ireland limited t/a sanofi - zolmitriptan - film coated tablet - 2.5 milligram

ZOLMITRIPTAN SANOFI 2.5 Milligram Orodispersible Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

zolmitriptan sanofi 2.5 milligram orodispersible tablet

sanofi-aventis ireland limited t/a sanofi - zolmitriptan - orodispersible tablet - 2.5 milligram

MAALOX SUGAR-FREE CHEWABLE TABLETS 400/400 Milligram Tablets Chewable Ireland - English - HPRA (Health Products Regulatory Authority)

maalox sugar-free chewable tablets 400/400 milligram tablets chewable

sanofi-aventis ireland limited t/a sanofi - aluminium oxide hydrated, magnesium hydroxide - tablets chewable - 400/400 milligram - combinations - for the relief of the symptoms of dyspepsia.

Telfast Allergy 120 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

telfast allergy 120 mg film-coated tablets

sanofi-aventis ireland limited t/a sanofi - fexofenadine hydrochloride - film-coated tablet - 120 milligram(s) - other antihistamines for systemic use; fexofenadine

Telfast 120 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

telfast 120 mg film-coated tablets

sanofi-aventis ireland limited t/a sanofi - fexofenadine hydrochloride - film-coated tablet - 120 milligram(s) - other antihistamines for systemic use; fexofenadine

Telfast 180 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

telfast 180 mg film-coated tablets

sanofi-aventis ireland limited t/a sanofi - fexofenadine hydrochloride - film-coated tablet - 180 milligram(s) - other antihistamines for systemic use; fexofenadine

Maalox Plus 200 mg/175 mg/25 mg Oral Suspension Ireland - English - HPRA (Health Products Regulatory Authority)

maalox plus 200 mg/175 mg/25 mg oral suspension

sanofi-aventis ireland limited t/a sanofi - aluminium hydroxide; magnesium hydroxide; simeticone - oral suspension - 200 mg/175 mg/25 mg/5ml - antacids with antiflatulents; ordinary salt combinations and antiflatulents

LIFSAR PULMOJET 50/500 Microgram Powder for Inhalation Ireland - English - HPRA (Health Products Regulatory Authority)

lifsar pulmojet 50/500 microgram powder for inhalation

sanofi-aventis ireland limited t/a sanofi - salmeterol xinafoate, fluticasone propionate - powder for inhalation - 50/500 microgram - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics - adrenergics, inhalants; adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics. - lifsar pulmojet is indicated for the symptomatic treatment of adults with chronic obstructive pulmonary disease (copd) with a fev1 < 60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations and who have significant symptoms despite regular bronchodilator therapy.

Dioralyte Blackcurrant Powder for Oral Solution Ireland - English - HPRA (Health Products Regulatory Authority)

dioralyte blackcurrant powder for oral solution

sanofi-aventis ireland limited t/a sanofi - sodium chloride ; potassium chloride; glucose; disodium hydrogen citrate - powder for oral solution - 3.56g/0.47g/0.53g/0.30 gram(s) - oral rehydration salt formulations

Dioralyte Citrus Powder for Oral Solution Ireland - English - HPRA (Health Products Regulatory Authority)

dioralyte citrus powder for oral solution

sanofi-aventis ireland limited t/a sanofi - glucose; sodium chloride ; disodium hydrogen citrate; potassium chloride - powder for oral solution - 3.56 g/0.47g/0.53g/0.30 gram(s) - oral rehydration salt formulations